| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Common Stock | Options Exercise | $2,011,409 | +54,643 | +23% | $36.81 | 292,532 | 09 Nov 2021 | Direct | |
| transaction | XYL | Common Stock | Sale | $7,262,415 | -54,643 | -19% | $132.91 | 237,889 | 09 Nov 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Stock Option (Right to Buy) | Options Exercise | $0 | -54,643 | -49% | $0.000000 | 56,298 | 09 Nov 2021 | Common | 54,643 | $36.81 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on June 8, 2021. |
| F2 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 26,858 Shares were executed at a range of prices from $131.93 to $132.92. 27,785 Shares were executed at a range of prices from 132.93 to $133.75. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| F3 | These options are fully vested and exercisable. |